Exparel 133 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQPX5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,146
Award facts
- Contract value 100% obligated
- $46,146.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $46,146.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, on December 12, 2025. This delivery order is for EXPAREL 133 mg/10 ml vials and is expected to be completed by January 6, 2026. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will serve as the prime contractor with no identified subcontractors on this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $500 million ceiling and completion date of December 31, 2036. The PPV-G GEN V program is part of a broader $30.3 billion DLA acquisition strategy designed to ensure reliable pharmaceutical supply to military healthcare facilities worldwide. EXPAREL is a specialty surgical pharmaceutical that represents one of many product categories DMS Pharmaceutical Group supplies under this prime vendor contract, positioning the company as a critical supplier within the Department of Defense's global medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQPX5?
SPE2DR26FQPX5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FQPX5 worth?
The government has obligated $46,146 on SPE2DR26FQPX5.
Is contract SPE2DR26FQPX5 an order under another contract?
Yes. SPE2DR26FQPX5 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQPX5 competed?
The extent of competition for SPE2DR26FQPX5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award